BamSEC and AlphaSense Join Forces
Learn More

Seaport Therapeutics Inc. – Material Contracts

NASDAQ: SPTX    
Share price (5/22/26): $17.50    
Market cap (5/22/26): $887 million
Search in Documents
Key Exhibits
External Links

Material Contracts Filter

EX-10.8
from S-1/A 3 pages Seaport Therapeutics, Inc. Non-Employee Director Compensation Policy
12/34/56
EX-10.7
from S-1/A 17 pages Seaport Therapeutics, Inc. Executive Severance Plan and Summary Plan Description
12/34/56
EX-10.3
from S-1/A 10 pages Seaport Therapeutics, Inc. 2026 Employee Stock Purchase Plan
12/34/56
EX-10.2
from S-1/A 41 pages Seaport Therapeutics, Inc. 2026 Stock Option and Incentive Plan
12/34/56
EX-10.15
from S-1 37 pages Certain Identified Information Has Been Excluded (Indicated By: [***]) From the Exhibit Because It Is Both (I) Not Materials and (II) the Type of Information That the Registrant Customarily and Actually Treats as Private or Confidential
12/34/56
EX-10.14
from S-1 52 pages Certain Information Contained in This Exhibit, Marked by [***], Has Been Excluded From This Exhibit Because the Registrant Has Determined That It Is Both Not Material and Is the Type That the Registrant Treats as Private or Confidential. Asset Transfer Agreement by and Between Seaport Therapeutics, Inc., on the One Hand, and Puretech Health LLC, and Puretech Lyt, Inc., on the Other Hand Dated as of April 8, 2024
12/34/56
EX-10.12
from S-1 9 pages Material contract
12/34/56
EX-10.11
from S-1 9 pages Material contract
12/34/56
EX-10.10
from S-1 11 pages Material contract
12/34/56
EX-10.9
from S-1 7 pages Seaport Therapeutics, Inc. Compensation Recovery Policy Adopted as of April 7, 2026, Subject to Effectiveness of the Company’s Registration Statement on Form S-1 for Its Initial Public Offering
12/34/56
EX-10.8
from S-1 3 pages Seaport Therapeutics, Inc. Non-Employee Director Compensation Policy
12/34/56
EX-10.7
from S-1 17 pages Seaport Therapeutics, Inc. Executive Severance Plan and Summary Plan Description
12/34/56
EX-10.6
from S-1 3 pages Seaport Therapeutics, Inc. Senior Executive Cash Incentive Bonus Plan
12/34/56
EX-10.5
from S-1 17 pages Seaport Therapeutics, Inc. Form of Indemnification Agreement
12/34/56
EX-10.4
from S-1 17 pages Seaport Therapeutics, Inc. Model Indemnification Agreement
12/34/56
EX-10.1
from S-1 19 pages Seaport Therapeutics, Inc. Amendment to 2024 Equity Incentive Plan
12/34/56
EX-10.11
from DRS/A 37 pages Certain Identified Information Has Been Excluded (Indicated By: [***]) From the Exhibit Because It Is Both (I) Not Materials and (II) the Type of Information That the Registrant Customarily and Actually Treats as Private or Confidential
12/34/56
EX-10.10
from DRS/A 52 pages Certain Information Contained in This Exhibit, Marked by [***], Has Been Excluded From This Exhibit Because the Registrant Has Determined That It Is Both Not Material and Is the Type That the Registrant Treats as Private or Confidential. Asset Transfer Agreement by and Between Seaport Therapeutics, Inc., on the One Hand, and Puretech Health LLC, and Puretech Lyt, Inc., on the Other Hand Dated as of April 8, 2024
12/34/56
EX-10.1
from DRS 19 pages Seaport Therapeutics, Inc. Amendment to 2024 Equity Incentive Plan
12/34/56